Literature DB >> 18680175

Stability of a trivalent recombinant protein vaccine formulation against botulinum neurotoxin during storage in aqueous solution.

Christina Vessely1, Tia Estey, Theodore W Randolph, Ian Henderson, Julianne Cooper, Rajiv Nayar, Latoya Jones Braun, John F Carpenter.   

Abstract

The adsorption of recombinant botulinum neurotoxin (BoNT) protein-derived vaccine antigens to aluminum salt adjuvants has been previously studied for the development of a trivalent vaccine against the neurotoxins (Vessely et al., in press, J Pharm Sci). The current paper describes an investigation of the stability of recombinant BoNT antigens adsorbed to aluminum salt adjuvants during storage in aqueous solution. Both chemical and physical changes occurred during storage. Phosphate groups in the buffer exchanged with hydroxyl groups on the adjuvant surface. The resulting changes in solution pH and adjuvant surface chemistry promoted more favorable electrostatic interaction between the BoNT proteins and the surface, possibly increasing the affinity of the proteins for the surface during storage. Fluorescence and UV spectroscopy suggested changes to protein structure during storage, whereas differential scanning calorimetry showed changes to thermal processes related to protein conformation and/or surface adsorption. The consequence of the chemical and physical changes to the proteins was a decrease in the ability to desorb protein from the adjuvant surface during storage. Overall, the results of this study emphasize the utility of a thorough characterization of the interactions between protein antigens and aluminum salt adjuvants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18680175      PMCID: PMC2721018          DOI: 10.1002/jps.21498

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  32 in total

Review 1.  Recent developments in adjuvants for vaccines against infectious diseases.

Authors:  D T O'Hagan; M L MacKichan; M Singh
Journal:  Biomol Eng       Date:  2001-10-15

2.  Change in the degree of adsorption of proteins by aluminum-containing adjuvants following exposure to interstitial fluid: freshly prepared and aged model vaccines.

Authors:  Y Shi; H HogenEsch; S L Hem
Journal:  Vaccine       Date:  2001-10-12       Impact factor: 3.641

3.  A Particle-Level Model of Irreversible Protein Adsorption with a Postadsorption Transition.

Authors: 
Journal:  J Colloid Interface Sci       Date:  1998-11-15       Impact factor: 8.128

4.  IR spectral changes of bovine serum albumin upon surface adsorption.

Authors:  T J Lenk; B D Ratner; R M Gendreau; K K Chittur
Journal:  J Biomed Mater Res       Date:  1989-06

5.  Effects of adsorption to aluminum salt adjuvants on the structure and stability of model protein antigens.

Authors:  LaToya S Jones; Laura J Peek; Jonathan Power; Aaron Markham; Brian Yazzie; C Russell Middaugh
Journal:  J Biol Chem       Date:  2005-01-31       Impact factor: 5.157

6.  Adsorption of poly(ethylene glycol)-modified lysozyme to silica.

Authors:  Susan M Daly; Todd M Przybycien; Robert D Tilton
Journal:  Langmuir       Date:  2005-02-15       Impact factor: 3.882

7.  Evaluation of chemical degradation of a trivalent recombinant protein vaccine against botulinum neurotoxin by LysC peptide mapping and MALDI-TOF mass spectrometry.

Authors:  Tia Estey; Christina Vessely; Theodore W Randolph; Ian Henderson; Latoya Jones Braun; Rajiv Nayar; John F Carpenter
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

8.  Relationship between the degree of antigen adsorption to aluminum hydroxide adjuvant in interstitial fluid and antibody production.

Authors:  Seema Iyer; Harm HogenEsch; Stanley L Hem
Journal:  Vaccine       Date:  2003-03-07       Impact factor: 3.641

9.  Biodegradable and biocompatible poly(DL-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies.

Authors:  J H Eldridge; J K Staas; J A Meulbroek; T R Tice; R M Gilley
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants.

Authors:  Christina Vessely; Tia Estey; Theodore W Randolph; Ian Henderson; Rajiv Nayar; John F Carpenter
Journal:  J Pharm Sci       Date:  2007-09       Impact factor: 3.534

View more
  16 in total

1.  Structural and immunological analysis of anthrax recombinant protective antigen adsorbed to aluminum hydroxide adjuvant.

Authors:  Leslie Wagner; Anita Verma; Bruce D Meade; Karine Reiter; David L Narum; Rebecca A Brady; Stephen F Little; Drusilla L Burns
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

2.  Working together: interactions between vaccine antigens and adjuvants.

Authors:  Christopher B Fox; Ryan M Kramer; Lucien Barnes V; Quinton M Dowling; Thomas S Vedvick
Journal:  Ther Adv Vaccines       Date:  2013-05

3.  The role of adjuvant in mediating antigen structure and stability.

Authors:  Latoya Jones Braun; Aimee M Eldridge; Jessica Cummiskey; Kelly K Arthur; Deborah S Wuttke
Journal:  J Pharm Sci       Date:  2011-12-28       Impact factor: 3.534

4.  The immunogenicity of thin-film freeze-dried, aluminum salt-adjuvanted vaccine when exposed to different temperatures.

Authors:  Sachin G Thakkar; Tinashe B Ruwona; Robert O Williams; Zhengrong Cui
Journal:  Hum Vaccin Immunother       Date:  2017-01-04       Impact factor: 3.452

Review 5.  Vaccines with aluminum-containing adjuvants: optimizing vaccine efficacy and thermal stability.

Authors:  Tanya Clapp; Paul Siebert; Dexiang Chen; LaToya Jones Braun
Journal:  J Pharm Sci       Date:  2010-08-25       Impact factor: 3.534

6.  In Vivo Synthesis of Cyclic-di-GMP Using a Recombinant Adenovirus Preferentially Improves Adaptive Immune Responses against Extracellular Antigens.

Authors:  Fadel S Alyaqoub; Yasser A Aldhamen; Benjamin J Koestler; Eric L Bruger; Sergey S Seregin; Cristiane Pereira-Hicks; Sarah Godbehere; Christopher M Waters; Andrea Amalfitano
Journal:  J Immunol       Date:  2016-01-20       Impact factor: 5.422

7.  The mechanisms of action of vaccines containing aluminum adjuvants: an in vitro vs in vivo paradigm.

Authors:  Tirth Raj Ghimire
Journal:  Springerplus       Date:  2015-04-16

Review 8.  Current status and future directions of botulinum neurotoxins for targeting pain processing.

Authors:  Sabine Pellett; Tony L Yaksh; Roshni Ramachandran
Journal:  Toxins (Basel)       Date:  2015-11-04       Impact factor: 4.546

9.  Mechanism of immunopotentiation and safety of aluminum adjuvants.

Authors:  Harm Hogenesch
Journal:  Front Immunol       Date:  2013-01-10       Impact factor: 7.561

Review 10.  Unraveling the enigma: elucidating the relationship between the physicochemical properties of aluminium-based adjuvants and their immunological mechanisms of action.

Authors:  Emma Shardlow; Matthew Mold; Christopher Exley
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-07       Impact factor: 3.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.